Explore more Articles in

BioTech

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline in overall services activity in April. While surveys had previously indicated potential weakness...

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year,...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities,...
BioTech

Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside – Septerna (NASDAQ:SEPN)

On Monday, HC Wainwright initiated coverage on Septerna, Inc. SEPN, citing a next-generation drug design platform aimed at hitherto-undruggable targets.Septerna is working on G...
BioTech

Why Is Capricor Therapeutics Stock Trading Lower On Monday? – Capricor Therapeutics (NASDAQ:CAPR)

Capricor Therapeutics, Inc. CAPR stock is trading lower on Monday, with a session volume of 1.9 million compared to an average volume of 2.41...
BioTech

Why Is Cidara Therapeutics Stock Trading Higher On Monday? – Cidara Therapeutics (NASDAQ:CDTX)

Cidara Therapeutics, Inc. CDTX stock is trading over 90% higher on Monday with a session volume of 3.2 million compared to the average volume...
BioTech

Eli Lilly’s Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns – Eli Lilly (NYSE:LLY)

Eli Lilly And Co LLY on Saturday announced detailed results from the ACHIEVE-1 Phase 3 trial of orforglipron compared to placebo in adults with...
BioTech

Novo Nordisk’s Weight Loss Injection CagriSema Data Sparks Investors Concern – Novo Nordisk (NYSE:NVO)

On Sunday, The New England Journal of Medicine (NEJM) published results from Novo Nordisk A/S‘ NVO phase 3 REDEFINE 1 trial of CagriSema plus...
BioTech

FDA Halts Trials Exporting Americans’ Cells To Hostile Countries For Genetic Engineering – CRISPR Therapeutics (NASDAQ:CRSP), Caribou Biosciences (NASDAQ:CRBU)

The U.S. Food and Drug Administration (FDA) on Wednesday initiated an immediate review of clinical trials that involved sending Americans’ living cells to China...
1...121314...18Page 13 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.